iShares Neuroscience and Healthcare ETF
IBRN
4 hedge funds and large institutions have $2.58M invested in iShares Neuroscience and Healthcare ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
7.85% more ownership
Funds ownership: 69.15% → 77.01% (+7.9%)
2% less capital invested
Capital invested by funds: $2.64M → $2.58M (-$50.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$290K |
| 2 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$4.07K |
Top Sellers
IBRN Hedge Fund Activity: Q1 2025 in Review
4 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q1 2025, worth a combined $2.58M — down 1.9% from $2.64M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IBRN positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Flow Traders U.S., opening a new position worth an estimated $290K.
- 4 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q1 2025, up from 2 in Q4 2024.
- Funds reported $2.58M of iShares Neuroscience and Healthcare ETF stock for Q1 2025, down 1.9% quarter-over-quarter.
- 2 funds opened new iShares Neuroscience and Healthcare ETF positions in Q1 2025 and 0 closed out, a net change of +2 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q1 2025 was Flow Traders U.S., an estimated $290K added.
Based on aggregated 13F filings for Q1 2025.